TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Slide background
Slide background
  • February 8, 2020

PHILADELPHIA, PA—PCI Pharma Services (PCI), a pharmaceutical and biopharmaceutical global supply chain solutions provider, has acquired Bellwyck Pharma Services, Toronto, Canada, a primary and secondary packaging and labeling provider for clinical trial and commercial drug markets. The acquisition will add four GMP-compliant facilities to PCI’s existing network, bringing the total to 25 GMP facilities in North America, Europe, and Asia Pacific. Additionally, the acquisition will allow PCI to establish a market presence in Canada and Germany. This is PCI’s third acquisition outside of the US in the last three years.